Renfeng Fan

Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen

Jianfeng He, X. Fang, yang-xin fu, 2021, medRxiv.

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial

Jianfeng He, X. Fang, F. Dèng, 2021, Emerging microbes & infections.

Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine:  a phase IV, open-label, single-center, randomized, non-inferiority trial.

Wenjun Ma, Zhenglun Liang, Zewu Zhang, 2019, The Journal of infectious diseases.

Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis

Jiayou Zhang, Xiaoming Yang, Kai Duan, 2020, Frontiers in Immunology.

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study

Xiaoming Yang, Kai Duan, Wei Chen, 2021, Human vaccines & immunotherapeutics.

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial

Jianfeng He, X. Fang, F. Dèng, 2021, Emerging Microbes & Infections.